Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - cancer+inhibition
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Bioelectric Neuromodulation Methods for Hematopoiesis Regulation During Chemotherapy (Case No. 2020-382)
Summary: UCLA researchers in the Department of Bioengineering have developed an electrical neuromodulation method to accelerate recovery from deleterious chemotherapy side effects to improve patient outcome. Background: Chemotherapy works by targeting and killing fast-growing cancer cells using anti-cancer drugs. However, because these drugs lack...
Published: 8/21/2025
|
Inventor(s):
Wentai Liu
Keywords(s):
algorithmic cancer detection
,
Bladder Cancer
,
blood cancers
,
Brain cancer
,
Breast Cancer
,
Cancer
,
cancer antigen
,
cancer detection
,
Cancer Immunotherapy
,
cancer inhibition
,
cancer metabolism
,
Cancer stem cells
,
cancer target
,
castration resistant prostate cancer
,
Chemotherapy
,
head and neck cancer
,
lympathic cancers
,
lymphatic cancer
,
Mesenchymal Stem Cell Derived Cancer Cells
,
Neuromodulation
,
non-small cell lung cancer
,
Orthotopic cancer models
,
Pancreatic cancer
,
prostate cancer
,
small cell cancer
,
small cell lung cancer
,
small cell prostate cancer
Category(s):
Medical Devices
,
Medical Devices > Neural Stimulation
,
Chemical
,
Electrical
,
Therapeutics
,
Therapeutics > Oncology
Small Molecules that Inhibit RNA Binding Protein IGF2BP3 in Cancer (UCLA Case No. 2023-215)
UCLA researchers in the Department of Pathology and Laboratory Medicine have developed small molecules which inhibits the protein IGF2BP3, a highly expressed oncofetal protein in certain cancers, especially in B-acute lymphoblastic leukemia. BACKGROUND: Cancer remains the second leading cause of death in the U.S. Advancements in targeted therapies...
Published: 7/17/2025
|
Inventor(s):
Dinesh Rao
Keywords(s):
blood cancers
,
Cancer
,
cancer inhibition
,
leukemia
Category(s):
Therapeutics > Oncology